FM
Fady Ibraham Malik (EVP Research & Development) filed 19 Form 4 reports in the trailing twelve months (0 purchases, 19 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
19
0 buys · 19 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.7M
shares × price, as filed
Last traded
Nov 3
Filed Nov 3
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
19 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$220K3,500 sh × $62.93
Exec Nov 3
Filed Nov 3 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $224K
3,500 sh × $64.01
Exec Oct 20
Filed Oct 20 · 4:21 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $215K
3,500 sh × $61.38
Exec Oct 6
Filed Oct 6 · 4:25 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $239K
3,500 sh × $68.29
Exec Sep 22
Filed Sep 22 · 6:14 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $264K
3,500 sh × $75.46
Exec Sep 8
Filed Sep 8 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $265K
3,500 sh × $75.82
Exec Aug 18
Filed Aug 18 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $282K
3,500 sh × $80.59
Exec Jul 21
Filed Jul 23 · 4:09 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $303K
3,500 sh × $86.62
Exec Jul 7
Filed Jul 7 · 5:06 PM ET More filings →